P. Rouanet
Papers
1
Total Citations
14
H-Index
1
About
P. Rouanet is a leading figure in colorectal surgical oncology, with a primary focus on optimizing treatment strategies for rectal cancer, particularly through organ-preserving approaches. His major contributions center on evaluating the efficacy of local excision versus total mesorectal excision in patients who achieve a good response after neoadjuvant radiochemotherapy. As the principal investigator of the landmark GRECCAR 2 randomized phase 3 trial, Rouanet provided pivotal preliminary evidence that local excision can be a safe alternative for carefully selected patients with T2-T3 low rectal cancer, reducing morbidity without compromising oncological outcomes. This work, published in 2014 and cited over 140 times, has helped shift clinical practice toward more tailored, less invasive interventions. Rouanet’s research is instrumental in advancing the paradigm of sphincter preservation and quality of life for rectal cancer patients, making him a key voice in the ongoing debate between radical surgery and conservative management. His contributions continue to influence guidelines and inspire further trials in precision oncology for rectal malignancies.
Research Focus
Key Achievements
Top Papers
- 1